Retour aux projets

15811.2;8 PFLS-LS

Tailoring selectivity profiles for targeted cancer therapy and orphan diseases - PI3K/mTOR drugs

Résumé

Tailoring selectivity profiles for targeted cancer therapy and orphan diseases - PI3K/mTOR drugs

Textes supplémentaires

Abstract

PIQUR and UniBas engage into a project that aims to provide PIQUR access to accelerated drug registration, and UniBas the opportunity to explore PI3K/mTOR-dependent processes in physiology and disease to broaden therapy relevant knowledge and targeting of PI3K/mTOR driven disease processes. Focal themes are differentiation of the PIQUR portfolio, innovative chemistry, and the elucidation of novel biological signaling mechanisms.

Participants

Matthias Wymann

Kontaktperson

matthias.wymann@unibas.ch

Universität Basel Matthias Wymann Mattenstrasse 28 4058 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2013-11-30
Date de fin
2015-11-12
Coûts totaux approuvés
CHF 437760.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%